Senior Advisory for Emerging Biotechs

Payer strategy for emerging biotechs.

Clear pricing, reimbursement, and market access guidance before key decisions that affect asset value.

Access Navigate helps emerging biotech teams build payer strategy before key decision milestones.

We support preclinical, Phase 1, Phase 2, Phase 3, and pre-launch teams preparing for clinical development, investor meetings, BD partnering, licensing, acquisition, diligence, and launch.

Strategic Imperative

Why Payer Strategy Matters Earlier Than Most Teams Expect

Pricing, reimbursement, and access shape value long before approval. They affect indication choice, trial design, comparators, endpoints, evidence planning, investor valuation, BD strategy, and launch sequencing.

Access Navigate is a specialized advisory for biotech CEOs, CBOs, BD teams, clinical leaders, investors, and scientific founders who need senior payer strategy input before important decisions.

Core Insights

Three Payer Questions Shape Asset Value

Understanding these questions early informs critical decisions that protect and enhance your asset's potential.

Pricing Potential

Reimbursement & Access

Payer Strategy Roadmap

What is the realistic price, and what evidence is needed to support it?

How would payers cover, restrict, or value your product?

What is the payer value proposition, evidence plan, and access roadmap?

Our Clients

Strategic Guidance for Biotech Leaders

CEOs & CBOs

Define market access strategy, build pricing assumptions, and prepare for BD partnering and commercial diligence.

Clinical Development Teams

Align trial design, endpoints, and evidence planning with future payer requirements for optimal asset value.

Investors

Validate commercial assumptions, assess payer risk, and understand market access implications for asset valuation and financing rounds.

Scientific Founders

Translate scientific innovation into a compelling payer value proposition that secures future market access and reimbursement.

Engagement Models

Services at a Glance

Payer Readiness Diagnostic

Payer Strategy Hypothesis

Early read on price potential, reimbursement risk, payer evidence gaps, and value implications.

Senior advisory engagement to define payer strategy, build pricing assumptions, and outline an access roadmap.

Flexible Market Access Retainer

Ongoing senior payer strategy support to navigate evolving market dynamics and critical milestones.